INSL4

(redirected from EPIL)
Also found in: Acronyms.

INSL4

A gene on chromosome 9p24 that encodes insulin-like 4 protein, a member of the insulin superfamily, which may play an important role in trophoblast development and in regulating bone formation. It is expressed in placenta, uterus and in foetal perichondrium.

Molecular pathology
INSL4 is highly expressed in early placentas and molar pregnancies, and is reduced in choriocarcinoma.
References in periodicals archive ?
Peter Wood, of Harris Lamb, which advised EPIL, said: "The building is particularly significant as Louisa Ryland was a generous benefactor to the city of Birmingham and EPIL, which is the family office of the Majid family, is a major employer.
But now the Congress government says the EPIL is not involved in the Kedarnath redevelopment project and will perform assignments as advised by the Centre.
15 billion in senior fixed and floating notes in November 2004, partially offset by the repayment of the EPIL III notes, the retirement of $242.
Elan has guaranteed loan notes issued by EPIL II (a QSPE, which is not consolidated under U.
0% of the aggregate principal amount of the outstanding EPIL Notes), which may increase to $21 million (2.
Elan has guaranteed loan notes issued by EPIL II, a QSPE, which is not consolidated, to the extent that the investments held by it are insufficient to repay the loan notes and accrued interest when they fall due.
Shelly Bay acquired certain financial assets from EPIL III on June 29, 2002.
The agreements extend to September 5, 2003, the EPIL II and EPIL III noteholders' waivers of compliance by Elan with certain provisions of the documents governing the EPIL II and EPIL III notes that required Elan to provide the noteholders with Elan's 2002 audited consolidated financial statements by June 29, 2003.
The agreements extend to August 29, 2003, the EPIL II and EPIL III noteholders' waivers of compliance by Elan with certain provisions of the documents governing the EPIL II and EPIL III notes that required Elan to provide the noteholders with Elan's 2002 audited consolidated financial statements by June 29, 2003.